The overall approach in no-deal Brexit is for the MHRA to be a stand-alone medicines and medical devices regulator, taking any decisions and carrying out any functions which are…
In August 2018, a review by the Chief Medical Officer recommended moving cannabis-based medicinal products out of Schedule 1 of the Misuse of Drugs Regulations 2001 ('the 2001…
The Society submitted a written response to the ‘Prescribing and standards for medicines management’ consultation launched by NMC which highlighted the nurse and midwifery prescribing…
The Society responded to the Research Integrity Inquiry, which was based on the issues raised in the POSTnote (Integrity in Research, Number 544.) Overall, the Society noted that…
In March 2016, the Society had responded to the call for evidence for the Research Excellence Framework (REF) review by Lord Nicholas Stern to highlight particular areas of concern…
The Department for Business, Innovation and Skills have consulted on Higher education: teaching excellence, social mobility and student choice green paper. The Society sought views of…
This consultation sought views on how a limit on immigration should work. It included questions about the coverage of limits as well as the mechanics of how they will work in…
In January 2016, the Society was approached to contribute to Sir William Wakeham's review of STEM degree provision and graduate employability. The review looked at the provision of…
The Welsh Government recently sought comments on a series of recommendations for the improvement of the appraisal process of orphan and ultra-orphan medicines in Wales. The Society…
The United Nations Secretary-General’s High-Level Panel on Access to Medicines consulted on promoting innovation and increasing access to medicines, vaccines, diagnostics and related…
